Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 7,175,939 |
|
|||||
| News | - | ||||||
| Day High | 1.06 | Low High |
|||||
| Day Low | 0.98 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Xilio Therapeutics Inc | XLO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.05 | 4.90% | 1.07 | 18:49:07 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.04 | 0.98 | 1.06 | 1.05 | 1.02 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 426 | 7,175,939 | $ 1.00 | $ 7,178,816 | - | 0.49 - 3.2499 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:42:51 | formt | 400 | $ 1.07 | USD |
Xilio Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 28.64M | 27.54M | - | 0 | -76.4M | -2.77 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Xilio Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical XLO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.9333 | 1.10 | 0.8801 | 1.05 | 161,486 | 0.1367 | 14.65% |
| 1 Month | 1.30 | 1.30 | 0.8366 | 1.07 | 195,437 | -0.23 | -17.69% |
| 3 Months | 0.631 | 1.93 | 0.58 | 1.25 | 1,298,386 | 0.439 | 69.57% |
| 6 Months | 0.8449 | 1.93 | 0.49 | 1.15 | 724,034 | 0.2251 | 26.64% |
| 1 Year | 2.96 | 3.2499 | 0.49 | 1.17 | 368,762 | -1.89 | -63.85% |
| 3 Years | 15.00 | 27.95 | 0.49 | 2.66 | 187,536 | -13.93 | -92.87% |
| 5 Years | 15.00 | 27.95 | 0.49 | 2.66 | 187,536 | -13.93 | -92.87% |
Xilio Therapeutics Description
| Xilio Therapeutics Inc is a biotechnology company focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer. Leveraging the GPS platform, they are building a pipeline of tumor-selective cytokine and checkpoint inhibitor immunotherapies to treat cancer. The goal is to overcome the limitations of current I-O therapies by developing products with an improved therapeutic index. |
